The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Broidrick Amy S. since 2021.
This trader's CIK number is 1822917.
At the time of last reporting, Broidrick Amy S. was the President/CSO of Qualigen Therapeutics, Inc.. (stock ticker symbol QLGN).
Also see all insider trading activities at Qualigen Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | QLGN | 30,000 | $18,600 | 0 | $0 | 0 | $0 |
| 2021 | QLGN | 4,500 | $9,135 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-06-14 | QLGN | Buy | 30,000 | .62 | 18,600 |
| 2021-04-26 | QLGN | Buy | 4,500 | 2.03 | 9,135 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Broidrick Amy S. (President/CSO of Qualigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.